Sign in

Lost your password?
(close)

Servier Australia

Last updated: 13.02.2014

Address: PO Box 196 Hawthorn Victoria 3122

Tel: (03) 8823 7333

Web: http://www.servier.com.au/home/default.asp

Company description

In just over 20 years, turnover has increased from $1 million in 1984 to $107 million for 2009. The number of people employed has risen steadily. The Sales force has grown from 6 representatives in 1984 spread across all Australian regions to in excess of 120 representatives today, but has maintained its reputation throughout this time as being amongst one of the best trained, most professional and most productive in Australia.

Servier’s activities in Australia commenced in 1979 with the launch of the anti-diabetic agent- Diamicron

Pivotal development work for the group’s flagship product Coversyl, which led to more than 30 publications from Australian researchers prior to marketing approval, culminated with the launch of Coversyl 2mg and 4mg in 1992.

In 1999 The International Centre for Therapeutic Research was established in Australia- The first outside of Europe and now has a staff in excess of 30 involved in phase l,ll and lll clinical research.

By January 1999 the company had outgrown it’s head office of 15 years and moved to it’s new purpose built office in Hawthorn, Melbourne, which saw the divisions of Sales/Marketing and Research all housed under the one roof.

Coversyl 8mg was launched in February 2004 and already contributes 21% of the Company annual turnover.

Coralan, a new treatment for chronic stable angina was registered in November 2006.

In April 2007, Protos, a new treatment for post menopausal osteoporosis was listed on the PBS.

Products and services

Servier Australia is the local subsidiary of Servier, a leading French research-based pharmaceutical entity, specialising in ethical pharmaceuticals. Employing over 200 people in Australia, its headquarters are in Hawthorn, Melbourne. In 2009 Servier Australia had an annual turnover of $107 million.

Servier Laboratories Limited comprises two principal divisions:

Clinical Research

The management of phase l, ll, lll and lV clinical trials in collaboration with research-based hospitals and general practices throughout Australia.

Sales and Marketing

Sales and Marketing deliver Servier’s portfolio of ethical pharmaceutical products to primary and secondary healthcare professionals
In addition to a team of representatives throughout Australia, to support the operational activities of the above divisions, there is naturally a complete range of professional support functions that include the following: Training, Medical Information (Marketing), Regulatory Affairs, Human Resources, Finance, Information Services, Strategic Coordination, External and Government Relations and Medical Affairs.

Servier Australia offers a range of products in a number of medical areas: cardiovascular disease, especially hypertension and cardiac disease, diabetes and more recently osteoporosis

Related

We use cookies to ensure that we give you the best experience on our site. For more info click here